NECLIFENSENectar Lifesciences Limited· PharmaceuticalsMediumPositive
Announced Tue, 27 Jan · 16:38 IST

sanjiv Goyal, Raman Goyal, Sanjiv (HUF) has submitted to the Exchange a copy of Disclosures under Regulation 10(6)-Report to stock Exchange in respect of any acquisition made in reliance upon exemption provided for in regulation 10 of SEBI (SAST) Regulations, 2011.

Promoter Stake BuyOwnership Changes View source PDF

NECLIFE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Members of the promoter group of Nectar Lifesciences — Sanjiv Goyal, Raman Goyal, and Sanjiv (HUF) — have filed a disclosure with the stock exchange under Regulation 10(6) of the SEBI (Substantial Acquisition and Takeover) Regulations, 2011. This filing reports an acquisition they made by relying on the exemption available under Regulation 10, which typically covers inter se transfers between promoter-group members or between qualifying holders. No specific share quantity, price, or percentage figures are visible in the filing excerpt provided. Such transactions are exempt from triggering the mandatory open-offer requirement, meaning no public shareholders are being asked to tender shares.

Likely market impact

This is an internal reshuffle within the promoter group and does not change the overall promoter ownership of the company. Minority shareholders are unaffected as no open offer is triggered, and the stock price is unlikely to react materially to this news.